What are specific problems encountered in manufacturing orphan drugs? Given these problems, why would pharmaceutical companies develop them anyway?

Aside from the common ones like high costs, lack of knowledge and training, small market, what could be hindering the development of orphan drugs? And given these challenges, why would companies...

09 September 2016 3,479 0 View